Daily News: November 4, 2013

Crossover Healthcare Fund Leads Pivotal Therapeutics Debt Financing

Pivotal Therapeutics announced it extended the closing date of the previously announced debt financing to November 30, 2013. Crossover Healthcare Fund led the transaction.

“The financing is progressing well, and to date we have received CDN $1.65 million of the $5 million debt financing, led by Crossover Healthcare Fund LLC,” stated Rachelle Mac Sweeney co-founder, president and COO.

Pivotal Therapeutics, with offices in Woodbridge, Ontario, Canada and Boca Raton, FL, is a publicly traded specialty pharmaceutical company with a focus on cardiovascular disease and overall health.